An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection

BACKGROUND/AIMS: In the Republic of Korea, an estimated 231,000 individuals have chronic hepatitis C virus (HCV) infection. The aim of the present analysis was to evaluate the safety and efficacy of elbasvir/grazoprevir (EBR/GZR) administered for 12 weeks in Korean patients who were enrolled in inte...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Mol Hepatol
Auteurs principaux: Lee, Youn Jae, Heo, Jeong, Kim, Do Young, Chung, Woo Jin, Tak, Won Young, Kim, Yoon Jun, Paik, Seung Woon, Sim, Eungeol, Kulasingam, Susila, Talwani, Rohit, Haber, Barbara, Hwang, Peggy
Format: Artigo
Langue:Inglês
Publié: The Korean Association for the Study of the Liver 2019
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6933128/
https://ncbi.nlm.nih.gov/pubmed/31132846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2019.0006
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires